

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | uronic acid metabolic process (GO:0006063) | 6.08353833 |
| 2 | glucuronate metabolic process (GO:0019585) | 6.08353833 |
| 3 | cellular glucuronidation (GO:0052695) | 5.88429170 |
| 4 | xenobiotic catabolic process (GO:0042178) | 5.44605693 |
| 5 | glyoxylate metabolic process (GO:0046487) | 5.07002839 |
| 6 | phenylpropanoid metabolic process (GO:0009698) | 4.93442617 |
| 7 | response to nitrosative stress (GO:0051409) | 4.66908793 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 4.32206502 |
| 9 | regulation of cardioblast differentiation (GO:0051890) | 3.91741018 |
| 10 | benzene-containing compound metabolic process (GO:0042537) | 3.87800958 |
| 11 | epoxygenase P450 pathway (GO:0019373) | 3.79125598 |
| 12 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.69364435 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.57991951 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 3.57991951 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 3.41243532 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.41243532 |
| 17 | paraxial mesoderm development (GO:0048339) | 3.40020202 |
| 18 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.36374077 |
| 19 | hormone catabolic process (GO:0042447) | 3.35760171 |
| 20 | gap junction assembly (GO:0016264) | 3.34809275 |
| 21 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.34770295 |
| 22 | embryonic foregut morphogenesis (GO:0048617) | 3.34490068 |
| 23 | bile acid biosynthetic process (GO:0006699) | 3.29812568 |
| 24 | tryptophan metabolic process (GO:0006568) | 3.28126278 |
| 25 | cysteine metabolic process (GO:0006534) | 3.27767060 |
| 26 | glutathione metabolic process (GO:0006749) | 3.25237356 |
| 27 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.24519234 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 3.24354273 |
| 29 | regulation of bile acid biosynthetic process (GO:0070857) | 3.23009068 |
| 30 | midgut development (GO:0007494) | 3.21344488 |
| 31 | tryptophan catabolic process (GO:0006569) | 3.18526034 |
| 32 | indole-containing compound catabolic process (GO:0042436) | 3.18526034 |
| 33 | indolalkylamine catabolic process (GO:0046218) | 3.18526034 |
| 34 | metanephric mesenchyme development (GO:0072075) | 3.18098883 |
| 35 | aromatic amino acid family catabolic process (GO:0009074) | 3.17996753 |
| 36 | L-ascorbic acid metabolic process (GO:0019852) | 3.16770031 |
| 37 | renal absorption (GO:0070293) | 3.12230110 |
| 38 | nuclear pore complex assembly (GO:0051292) | 3.11981772 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 3.11923094 |
| 40 | homocysteine metabolic process (GO:0050667) | 3.07384808 |
| 41 | negative regulation of fatty acid transport (GO:2000192) | 3.06370249 |
| 42 | regulation of cholesterol metabolic process (GO:0090181) | 3.06036595 |
| 43 | outer ear morphogenesis (GO:0042473) | 3.01997522 |
| 44 | kidney mesenchyme development (GO:0072074) | 3.00394188 |
| 45 | intestinal absorption (GO:0050892) | 2.99097171 |
| 46 | gastrulation with mouth forming second (GO:0001702) | 2.98105476 |
| 47 | carnitine metabolic process (GO:0009437) | 2.96809762 |
| 48 | plasma lipoprotein particle assembly (GO:0034377) | 2.95299500 |
| 49 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.92981483 |
| 50 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.92920439 |
| 51 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.92429831 |
| 52 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.92429831 |
| 53 | pre-miRNA processing (GO:0031054) | 2.91581606 |
| 54 | flavonoid metabolic process (GO:0009812) | 2.91143229 |
| 55 | lysine catabolic process (GO:0006554) | 2.89442898 |
| 56 | lysine metabolic process (GO:0006553) | 2.89442898 |
| 57 | kynurenine metabolic process (GO:0070189) | 2.88961926 |
| 58 | positive regulation of catenin import into nucleus (GO:0035413) | 2.86136641 |
| 59 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.85090572 |
| 60 | glutathione derivative biosynthetic process (GO:1901687) | 2.83937848 |
| 61 | glutathione derivative metabolic process (GO:1901685) | 2.83937848 |
| 62 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.83346396 |
| 63 | cellular modified amino acid catabolic process (GO:0042219) | 2.83233064 |
| 64 | dorsal/ventral axis specification (GO:0009950) | 2.82675950 |
| 65 | high-density lipoprotein particle remodeling (GO:0034375) | 2.82652062 |
| 66 | establishment of apical/basal cell polarity (GO:0035089) | 2.82316602 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.81441826 |
| 68 | epithelial cell-cell adhesion (GO:0090136) | 2.79505521 |
| 69 | bile acid metabolic process (GO:0008206) | 2.78476047 |
| 70 | urea metabolic process (GO:0019627) | 2.77039154 |
| 71 | urea cycle (GO:0000050) | 2.77039154 |
| 72 | nuclear pore organization (GO:0006999) | 2.76894354 |
| 73 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.76377291 |
| 74 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.74145965 |
| 75 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.73203006 |
| 76 | anterior/posterior axis specification, embryo (GO:0008595) | 2.72827463 |
| 77 | reverse cholesterol transport (GO:0043691) | 2.72825885 |
| 78 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.72388775 |
| 79 | aldehyde catabolic process (GO:0046185) | 2.69321645 |
| 80 | negative regulation of fibrinolysis (GO:0051918) | 2.68435382 |
| 81 | notochord development (GO:0030903) | 2.68031478 |
| 82 | protein-lipid complex assembly (GO:0065005) | 2.67903660 |
| 83 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.66207404 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 2.65612352 |
| 85 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.64700365 |
| 86 | retinal rod cell development (GO:0046548) | 2.63966190 |
| 87 | drug transmembrane transport (GO:0006855) | 2.63551255 |
| 88 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.63502256 |
| 89 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.63231322 |
| 90 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.63071650 |
| 91 | regulation of gene silencing by miRNA (GO:0060964) | 2.63071650 |
| 92 | regulation of gene silencing by RNA (GO:0060966) | 2.63071650 |
| 93 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.62740047 |
| 94 | galactose metabolic process (GO:0006012) | 2.61038916 |
| 95 | convergent extension (GO:0060026) | 2.60794042 |
| 96 | Notch signaling involved in heart development (GO:0061314) | 2.59437693 |
| 97 | negative regulation of lipase activity (GO:0060192) | 2.58617426 |
| 98 | regulation of protein activation cascade (GO:2000257) | 2.58095411 |
| 99 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.57963481 |
| 100 | negative regulation of hormone metabolic process (GO:0032351) | 2.57354397 |
| 101 | omega-hydroxylase P450 pathway (GO:0097267) | 2.57240489 |
| 102 | amine catabolic process (GO:0009310) | 2.56831905 |
| 103 | cellular biogenic amine catabolic process (GO:0042402) | 2.56831905 |
| 104 | regulation of cholesterol esterification (GO:0010872) | 2.53353537 |
| 105 | polyol transport (GO:0015791) | 2.52748051 |
| 106 | polarized epithelial cell differentiation (GO:0030859) | 2.51989170 |
| 107 | drug catabolic process (GO:0042737) | 2.51602209 |
| 108 | morphogenesis of an epithelial sheet (GO:0002011) | 2.51511585 |
| 109 | regulation of skeletal muscle contraction (GO:0014819) | 2.51420700 |
| 110 | cellular amino acid catabolic process (GO:0009063) | 2.51244206 |
| 111 | regulation of fibrinolysis (GO:0051917) | 2.51221475 |
| 112 | fatty acid beta-oxidation (GO:0006635) | 2.50932940 |
| 113 | monocarboxylic acid catabolic process (GO:0072329) | 2.50586368 |
| 114 | hemidesmosome assembly (GO:0031581) | 2.49995892 |
| 115 | positive regulation of male gonad development (GO:2000020) | 2.49744547 |
| 116 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.49309390 |
| 117 | regulation of cell fate specification (GO:0042659) | 2.49171275 |
| 118 | indolalkylamine metabolic process (GO:0006586) | 2.48963528 |
| 119 | phospholipid homeostasis (GO:0055091) | 2.48504252 |
| 120 | neural crest cell development (GO:0014032) | 2.47757604 |
| 121 | 2-oxoglutarate metabolic process (GO:0006103) | 2.47756973 |
| 122 | mammary gland development (GO:0030879) | 2.46036994 |
| 123 | regulation of complement activation (GO:0030449) | 2.45867281 |
| 124 | desmosome organization (GO:0002934) | 2.44819883 |
| 125 | hippo signaling (GO:0035329) | 2.44809851 |
| 126 | intestinal cholesterol absorption (GO:0030299) | 2.43390392 |
| 127 | carboxylic acid catabolic process (GO:0046395) | 2.43235380 |
| 128 | organic acid catabolic process (GO:0016054) | 2.43235380 |
| 129 | tyrosine metabolic process (GO:0006570) | 2.42188996 |
| 130 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.41756237 |
| 131 | protein carboxylation (GO:0018214) | 2.41756237 |
| 132 | removal of superoxide radicals (GO:0019430) | 2.41196728 |
| 133 | cellular response to superoxide (GO:0071451) | 2.41196728 |
| 134 | cellular response to oxygen radical (GO:0071450) | 2.41196728 |
| 135 | branched-chain amino acid catabolic process (GO:0009083) | 2.40864919 |
| 136 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.39779663 |
| 137 | alpha-amino acid catabolic process (GO:1901606) | 2.39414087 |
| 138 | nitrogen cycle metabolic process (GO:0071941) | 2.39105249 |
| 139 | lung-associated mesenchyme development (GO:0060484) | 2.38755939 |
| 140 | excretion (GO:0007588) | 2.38115144 |
| 141 | regulation of cholesterol homeostasis (GO:2000188) | 2.37964507 |
| 142 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.37921290 |
| 143 | xenobiotic metabolic process (GO:0006805) | 2.37869142 |
| 144 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.37412161 |
| 145 | biotin metabolic process (GO:0006768) | 2.35572383 |
| 146 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.32222089 |
| 147 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.31898892 |
| 148 | atrioventricular valve morphogenesis (GO:0003181) | 2.31661926 |
| 149 | cardiac myofibril assembly (GO:0055003) | 2.30364034 |
| 150 | establishment of monopolar cell polarity (GO:0061162) | 2.29923385 |
| 151 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.29923385 |
| 152 | COPII vesicle coating (GO:0048208) | 2.26625571 |
| 153 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.23836691 |
| 154 | negative regulation of cell fate specification (GO:0009996) | 2.23340884 |
| 155 | doxorubicin metabolic process (GO:0044598) | 2.22978768 |
| 156 | daunorubicin metabolic process (GO:0044597) | 2.22978768 |
| 157 | polyketide metabolic process (GO:0030638) | 2.22978768 |
| 158 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.22675452 |
| 159 | mesenchymal cell proliferation (GO:0010463) | 2.22257704 |
| 160 | apical protein localization (GO:0045176) | 2.22101505 |
| 161 | plasma lipoprotein particle remodeling (GO:0034369) | 2.19988378 |
| 162 | protein-lipid complex remodeling (GO:0034368) | 2.19988378 |
| 163 | macromolecular complex remodeling (GO:0034367) | 2.19988378 |
| 164 | ectodermal placode formation (GO:0060788) | 2.19187988 |
| 165 | cell migration involved in gastrulation (GO:0042074) | 2.18636006 |
| 166 | cholesterol efflux (GO:0033344) | 2.18394358 |
| 167 | regulation of catenin import into nucleus (GO:0035412) | 2.17272322 |
| 168 | alpha-linolenic acid metabolic process (GO:0036109) | 2.17134970 |
| 169 | atrial septum morphogenesis (GO:0060413) | 2.16862047 |
| 170 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.15996680 |
| 171 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 2.15744064 |
| 172 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.15676916 |
| 173 | chondrocyte proliferation (GO:0035988) | 2.15511209 |
| 174 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.11452031 |
| 175 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.11452031 |
| 176 | phospholipid efflux (GO:0033700) | 2.10874796 |
| 177 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.09486957 |
| 178 | ethanol oxidation (GO:0006069) | 2.09413860 |
| 179 | heterochromatin organization (GO:0070828) | 2.08917688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.80290982 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.33891170 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.22144111 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.20940879 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91810495 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.87911831 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.81346543 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.77307918 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.70361180 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.56491177 |
| 11 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.43879361 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.39969705 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.36538633 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.26292852 |
| 15 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.23377339 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.18120125 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06603024 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.05317188 |
| 19 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.02503865 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.96139716 |
| 21 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.95237559 |
| 22 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.95237559 |
| 23 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.95237559 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.90511444 |
| 25 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.87751431 |
| 26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.87495519 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77105623 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76641958 |
| 29 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.76537621 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75767450 |
| 31 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.75014954 |
| 32 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.74376635 |
| 33 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.71708624 |
| 34 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.71596070 |
| 35 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.70962170 |
| 36 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.70593741 |
| 37 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.67206563 |
| 38 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.64376794 |
| 39 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.63459744 |
| 40 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.62722813 |
| 41 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57376960 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.55228096 |
| 43 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.55058909 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53298615 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53298615 |
| 46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.45359526 |
| 47 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.43261626 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42981898 |
| 49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42276134 |
| 50 | * SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.36309320 |
| 51 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34203070 |
| 52 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.33821102 |
| 53 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33766575 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.30348980 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29115634 |
| 56 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28513398 |
| 57 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.28101789 |
| 58 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.26962535 |
| 59 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.26805562 |
| 60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26431947 |
| 61 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25730893 |
| 62 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.25236002 |
| 63 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24976173 |
| 64 | CJUN_26792858_Chip-Seq_BT549_Human | 1.24531085 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22866931 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22197123 |
| 67 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.22036522 |
| 68 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.21987118 |
| 69 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21884106 |
| 70 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.21402776 |
| 71 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18778940 |
| 72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16751431 |
| 73 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16631649 |
| 74 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.16051932 |
| 75 | RXR_22108803_ChIP-Seq_LS180_Human | 1.15387856 |
| 76 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15207964 |
| 77 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.15146491 |
| 78 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.14561126 |
| 79 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.13844966 |
| 80 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13772910 |
| 81 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13313105 |
| 82 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13203206 |
| 83 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12792639 |
| 84 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12439608 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11918723 |
| 86 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.11169214 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11030483 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10759636 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10313460 |
| 90 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10218330 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09238367 |
| 92 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08598144 |
| 93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07410985 |
| 94 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07181787 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07181787 |
| 96 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.05192390 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04399499 |
| 98 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03882997 |
| 99 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.03872156 |
| 100 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03425105 |
| 101 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.01690800 |
| 102 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00531635 |
| 103 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.00379720 |
| 104 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.99915559 |
| 105 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.99377999 |
| 106 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99206009 |
| 107 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.98868465 |
| 108 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.98841126 |
| 109 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98809856 |
| 110 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.98664595 |
| 111 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.97013407 |
| 112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96527383 |
| 113 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.96079002 |
| 114 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96005068 |
| 115 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95113664 |
| 116 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94720602 |
| 117 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94277146 |
| 118 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.94243025 |
| 119 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93787131 |
| 120 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.93365618 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92677107 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92526556 |
| 123 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90944251 |
| 124 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90617511 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90595095 |
| 126 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.90516771 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89079532 |
| 128 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.89053842 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88864657 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87681801 |
| 131 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87256841 |
| 132 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87242955 |
| 133 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86282045 |
| 134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86098328 |
| 135 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86026133 |
| 136 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86013946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.88763221 |
| 2 | MP0005360_urolithiasis | 3.59913073 |
| 3 | MP0008789_abnormal_olfactory_epithelium | 3.43535013 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.26159200 |
| 5 | MP0005499_abnormal_olfactory_system | 3.15683161 |
| 6 | MP0005394_taste/olfaction_phenotype | 3.15683161 |
| 7 | MP0010030_abnormal_orbit_morphology | 3.07551663 |
| 8 | MP0009053_abnormal_anal_canal | 3.02998146 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.69295822 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.68483387 |
| 11 | MP0003878_abnormal_ear_physiology | 2.52223386 |
| 12 | MP0005377_hearing/vestibular/ear_phenot | 2.52223386 |
| 13 | MP0005365_abnormal_bile_salt | 2.45135692 |
| 14 | MP0003195_calcinosis | 2.30581508 |
| 15 | MP0000566_synostosis | 2.25328356 |
| 16 | MP0003941_abnormal_skin_development | 2.20763412 |
| 17 | MP0001984_abnormal_olfaction | 2.13480937 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.09891437 |
| 19 | MP0002009_preneoplasia | 2.04922150 |
| 20 | MP0009384_cardiac_valve_regurgitation | 1.96354525 |
| 21 | MP0003252_abnormal_bile_duct | 1.89600413 |
| 22 | MP0002233_abnormal_nose_morphology | 1.84169339 |
| 23 | MP0001299_abnormal_eye_distance/ | 1.79569032 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.72996363 |
| 25 | MP0001293_anophthalmia | 1.68943219 |
| 26 | MP0005248_abnormal_Harderian_gland | 1.64248315 |
| 27 | MP0003186_abnormal_redox_activity | 1.59444093 |
| 28 | MP0003567_abnormal_fetal_cardiomyocyte | 1.57830808 |
| 29 | MP0002249_abnormal_larynx_morphology | 1.54950572 |
| 30 | MP0009250_abnormal_appendicular_skeleto | 1.54429842 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.53647342 |
| 32 | MP0009672_abnormal_birth_weight | 1.53201662 |
| 33 | MP0000049_abnormal_middle_ear | 1.49762873 |
| 34 | MP0005275_abnormal_skin_tensile | 1.47838111 |
| 35 | MP0000762_abnormal_tongue_morphology | 1.47703563 |
| 36 | MP0003942_abnormal_urinary_system | 1.46720819 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.46007445 |
| 38 | MP0005257_abnormal_intraocular_pressure | 1.45894440 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.45608655 |
| 40 | MP0000534_abnormal_ureter_morphology | 1.44760932 |
| 41 | MP0003868_abnormal_feces_composition | 1.42519741 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.40840411 |
| 43 | * MP0005332_abnormal_amino_acid | 1.37574573 |
| 44 | MP0000678_abnormal_parathyroid_gland | 1.31325594 |
| 45 | MP0005408_hypopigmentation | 1.30746396 |
| 46 | MP0003937_abnormal_limbs/digits/tail_de | 1.30666577 |
| 47 | MP0005503_abnormal_tendon_morphology | 1.28846338 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.28050664 |
| 49 | MP0002084_abnormal_developmental_patter | 1.27606628 |
| 50 | MP0003755_abnormal_palate_morphology | 1.23422818 |
| 51 | MP0003283_abnormal_digestive_organ | 1.22597699 |
| 52 | MP0003122_maternal_imprinting | 1.21494898 |
| 53 | MP0002098_abnormal_vibrissa_morphology | 1.20621739 |
| 54 | MP0001177_atelectasis | 1.17036522 |
| 55 | MP0004272_abnormal_basement_membrane | 1.16867416 |
| 56 | MP0002254_reproductive_system_inflammat | 1.15213955 |
| 57 | * MP0003984_embryonic_growth_retardation | 1.13717104 |
| 58 | * MP0002088_abnormal_embryonic_growth/wei | 1.11484348 |
| 59 | MP0010368_abnormal_lymphatic_system | 1.09740358 |
| 60 | * MP0005380_embryogenesis_phenotype | 1.08873722 |
| 61 | * MP0001672_abnormal_embryogenesis/_devel | 1.08873722 |
| 62 | MP0004957_abnormal_blastocyst_morpholog | 1.08025280 |
| 63 | MP0001666_abnormal_nutrient_absorption | 1.07127864 |
| 64 | MP0002938_white_spotting | 1.06718514 |
| 65 | MP0003123_paternal_imprinting | 1.05882694 |
| 66 | MP0005367_renal/urinary_system_phenotyp | 1.05618639 |
| 67 | MP0000516_abnormal_urinary_system | 1.05618639 |
| 68 | MP0002060_abnormal_skin_morphology | 1.05322061 |
| 69 | MP0001661_extended_life_span | 1.05021071 |
| 70 | MP0004264_abnormal_extraembryonic_tissu | 1.04777489 |
| 71 | MP0001730_embryonic_growth_arrest | 1.04664281 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.03789900 |
| 73 | MP0002085_abnormal_embryonic_tissue | 1.03589281 |
| 74 | MP0003115_abnormal_respiratory_system | 1.03477439 |
| 75 | MP0001346_abnormal_lacrimal_gland | 1.02828063 |
| 76 | MP0004043_abnormal_pH_regulation | 1.02322447 |
| 77 | MP0005409_darkened_coat_color | 1.01542344 |
| 78 | * MP0005197_abnormal_uvea_morphology | 1.01281301 |
| 79 | MP0009703_decreased_birth_body | 1.01021359 |
| 80 | MP0005171_absent_coat_pigmentation | 1.00901113 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.99497100 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 0.98384380 |
| 83 | MP0004885_abnormal_endolymph | 0.98155524 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.96561853 |
| 85 | MP0004084_abnormal_cardiac_muscle | 0.95861778 |
| 86 | MP0002796_impaired_skin_barrier | 0.95018050 |
| 87 | MP0005623_abnormal_meninges_morphology | 0.94778262 |
| 88 | MP0002089_abnormal_postnatal_growth/wei | 0.94646305 |
| 89 | MP0001286_abnormal_eye_development | 0.93916555 |
| 90 | MP0003279_aneurysm | 0.93729572 |
| 91 | MP0003890_abnormal_embryonic-extraembry | 0.93584579 |
| 92 | MP0000537_abnormal_urethra_morphology | 0.92356266 |
| 93 | MP0001915_intracranial_hemorrhage | 0.91737411 |
| 94 | MP0000613_abnormal_salivary_gland | 0.91427255 |
| 95 | MP0002282_abnormal_trachea_morphology | 0.90579168 |
| 96 | MP0010630_abnormal_cardiac_muscle | 0.90170122 |
| 97 | MP0002111_abnormal_tail_morphology | 0.89968998 |
| 98 | MP0005508_abnormal_skeleton_morphology | 0.88170780 |
| 99 | MP0003315_abnormal_perineum_morphology | 0.87758210 |
| 100 | MP0008932_abnormal_embryonic_tissue | 0.87587612 |
| 101 | MP0002653_abnormal_ependyma_morphology | 0.87484147 |
| 102 | MP0005391_vision/eye_phenotype | 0.87465673 |
| 103 | MP0006292_abnormal_olfactory_placode | 0.86759293 |
| 104 | MP0003385_abnormal_body_wall | 0.86660374 |
| 105 | MP0001697_abnormal_embryo_size | 0.85851208 |
| 106 | MP0000432_abnormal_head_morphology | 0.85116855 |
| 107 | MP0004858_abnormal_nervous_system | 0.84317241 |
| 108 | MP0000163_abnormal_cartilage_morphology | 0.84212451 |
| 109 | MP0003119_abnormal_digestive_system | 0.83965564 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.83309470 |
| 111 | MP0010352_gastrointestinal_tract_polyps | 0.83183089 |
| 112 | * MP0002697_abnormal_eye_size | 0.83077073 |
| 113 | MP0000538_abnormal_urinary_bladder | 0.81555224 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.81382514 |
| 115 | MP0009697_abnormal_copulation | 0.80591932 |
| 116 | MP0003950_abnormal_plasma_membrane | 0.80412948 |
| 117 | MP0005220_abnormal_exocrine_pancreas | 0.79121305 |
| 118 | MP0002116_abnormal_craniofacial_bone | 0.78884145 |
| 119 | MP0001849_ear_inflammation | 0.77970447 |
| 120 | MP0000467_abnormal_esophagus_morphology | 0.77086181 |
| 121 | MP0000647_abnormal_sebaceous_gland | 0.76655096 |
| 122 | * MP0004197_abnormal_fetal_growth/weight/ | 0.74953050 |
| 123 | MP0002277_abnormal_respiratory_mucosa | 0.74452068 |
| 124 | MP0006138_congestive_heart_failure | 0.73703085 |
| 125 | MP0003861_abnormal_nervous_system | 0.73681330 |
| 126 | MP0003935_abnormal_craniofacial_develop | 0.72511163 |
| 127 | MP0000462_abnormal_digestive_system | 0.72197103 |
| 128 | MP0002168_other_aberrant_phenotype | 0.70571441 |
| 129 | MP0004215_abnormal_myocardial_fiber | 0.69821624 |
| 130 | MP0000428_abnormal_craniofacial_morphol | 0.69676384 |
| 131 | MP0002092_abnormal_eye_morphology | 0.69601882 |
| 132 | MP0005319_abnormal_enzyme/_coenzyme | 0.69301407 |
| 133 | MP0002115_abnormal_skeleton_extremities | 0.69272239 |
| 134 | MP0005023_abnormal_wound_healing | 0.69211098 |
| 135 | MP0004134_abnormal_chest_morphology | 0.68887106 |
| 136 | MP0010678_abnormal_skin_adnexa | 0.68784082 |
| 137 | MP0000778_abnormal_nervous_system | 0.68727441 |
| 138 | MP0005187_abnormal_penis_morphology | 0.67611198 |
| 139 | MP0000579_abnormal_nail_morphology | 0.67582497 |
| 140 | MP0009780_abnormal_chondrocyte_physiolo | 0.67144622 |
| 141 | MP0003936_abnormal_reproductive_system | 0.66435028 |
| 142 | MP0002132_abnormal_respiratory_system | 0.66366162 |
| 143 | MP0005395_other_phenotype | 0.65990864 |
| 144 | MP0001270_distended_abdomen | 0.65906129 |
| 145 | MP0002109_abnormal_limb_morphology | 0.64994925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 3.83763403 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 3.44776505 |
| 3 | Renal tubular acidosis (HP:0001947) | 3.34935882 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 3.21673187 |
| 5 | Abnormality of cochlea (HP:0000375) | 3.10765175 |
| 6 | Hyperglycinemia (HP:0002154) | 2.97326186 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.88131724 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 2.82820733 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.82820733 |
| 10 | Chorioretinal atrophy (HP:0000533) | 2.81896952 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.80639533 |
| 12 | Lip pit (HP:0100267) | 2.75447046 |
| 13 | Epidermoid cyst (HP:0200040) | 2.61821214 |
| 14 | Ileus (HP:0002595) | 2.61805348 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 2.59274816 |
| 16 | Periauricular skin pits (HP:0100277) | 2.58682471 |
| 17 | Preauricular pit (HP:0004467) | 2.58682471 |
| 18 | Flat acetabular roof (HP:0003180) | 2.57183450 |
| 19 | Hepatocellular carcinoma (HP:0001402) | 2.52247907 |
| 20 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.50940763 |
| 21 | Partial duplication of thumb phalanx (HP:0009944) | 2.49521947 |
| 22 | Coronal craniosynostosis (HP:0004440) | 2.48241167 |
| 23 | Aplasia involving bones of the extremities (HP:0009825) | 2.47258060 |
| 24 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.47258060 |
| 25 | Aplasia of the phalanges of the hand (HP:0009802) | 2.47258060 |
| 26 | Hepatoblastoma (HP:0002884) | 2.41283780 |
| 27 | Papillary thyroid carcinoma (HP:0002895) | 2.40356484 |
| 28 | Follicular hyperkeratosis (HP:0007502) | 2.37051972 |
| 29 | Abnormality of the nasal septum (HP:0000419) | 2.35770243 |
| 30 | Lymphangioma (HP:0100764) | 2.35277755 |
| 31 | Vertebral clefting (HP:0008428) | 2.33888774 |
| 32 | Prolonged partial thromboplastin time (HP:0003645) | 2.33219953 |
| 33 | Hyperactive renin-angiotensin system (HP:0000841) | 2.29198693 |
| 34 | Fat malabsorption (HP:0002630) | 2.27662045 |
| 35 | Abnormality of chloride homeostasis (HP:0011422) | 2.27651351 |
| 36 | Xanthomatosis (HP:0000991) | 2.24890127 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 2.24829513 |
| 38 | Short hallux (HP:0010109) | 2.21706860 |
| 39 | Abnormality of carpal bone ossification (HP:0006257) | 2.20928666 |
| 40 | Choanal stenosis (HP:0000452) | 2.19393905 |
| 41 | Myelomeningocele (HP:0002475) | 2.19325469 |
| 42 | Hypolipoproteinemia (HP:0010981) | 2.17859586 |
| 43 | Preaxial foot polydactyly (HP:0001841) | 2.17522018 |
| 44 | Enlarged kidneys (HP:0000105) | 2.16387880 |
| 45 | Hypoplasia of the uterus (HP:0000013) | 2.15560426 |
| 46 | Septo-optic dysplasia (HP:0100842) | 2.15387312 |
| 47 | Partial duplication of the phalanx of hand (HP:0009999) | 2.15364511 |
| 48 | Deep venous thrombosis (HP:0002625) | 2.13236809 |
| 49 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.13001754 |
| 50 | Alopecia of scalp (HP:0002293) | 2.12419133 |
| 51 | Absent eyebrow (HP:0002223) | 2.12358076 |
| 52 | Neonatal short-limb short stature (HP:0008921) | 2.11593484 |
| 53 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.09996596 |
| 54 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.09638988 |
| 55 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.07412133 |
| 56 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.05235542 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.04567349 |
| 58 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.04003363 |
| 59 | Hydroxyprolinuria (HP:0003080) | 2.03342967 |
| 60 | Abnormality of proline metabolism (HP:0010907) | 2.03342967 |
| 61 | Subcapsular cataract (HP:0000523) | 2.03267080 |
| 62 | Potter facies (HP:0002009) | 2.02774475 |
| 63 | Facial shape deformation (HP:0011334) | 2.02774475 |
| 64 | Gout (HP:0001997) | 2.02214982 |
| 65 | Neoplasm of the adrenal gland (HP:0100631) | 2.02157237 |
| 66 | Hypoplastic scapulae (HP:0000882) | 2.02143804 |
| 67 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.02143804 |
| 68 | Protrusio acetabuli (HP:0003179) | 2.01286384 |
| 69 | Arterial tortuosity (HP:0005116) | 1.99690042 |
| 70 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99180624 |
| 71 | Skin pits (HP:0100276) | 1.98420936 |
| 72 | Hyperammonemia (HP:0001987) | 1.97744521 |
| 73 | Proximal tubulopathy (HP:0000114) | 1.96072732 |
| 74 | Hypoalphalipoproteinemia (HP:0003233) | 1.95812145 |
| 75 | Osteomalacia (HP:0002749) | 1.95779067 |
| 76 | Bifid tongue (HP:0010297) | 1.95721133 |
| 77 | Abnormal ossification of hand bones (HP:0005921) | 1.94856809 |
| 78 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.93929322 |
| 79 | Anal stenosis (HP:0002025) | 1.93829849 |
| 80 | Bronchomalacia (HP:0002780) | 1.93612756 |
| 81 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.93584540 |
| 82 | Alacrima (HP:0000522) | 1.93151539 |
| 83 | Turricephaly (HP:0000262) | 1.92477807 |
| 84 | Vaginal fistula (HP:0004320) | 1.92020978 |
| 85 | Rectal prolapse (HP:0002035) | 1.91013914 |
| 86 | Abnormal biliary tract morphology (HP:0012440) | 1.90764282 |
| 87 | Renal tubular dysfunction (HP:0000124) | 1.90726750 |
| 88 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.90668291 |
| 89 | Abnormal cartilage morphology (HP:0002763) | 1.90652703 |
| 90 | Abnormal hand bone ossification (HP:0010660) | 1.89999171 |
| 91 | Broad metatarsal (HP:0001783) | 1.88874247 |
| 92 | Cutaneous finger syndactyly (HP:0010554) | 1.88219155 |
| 93 | Abnormal tarsal ossification (HP:0008369) | 1.87664044 |
| 94 | Duplication of thumb phalanx (HP:0009942) | 1.87332291 |
| 95 | Acanthocytosis (HP:0001927) | 1.87060431 |
| 96 | Premature rupture of membranes (HP:0001788) | 1.87034803 |
| 97 | Missing ribs (HP:0000921) | 1.86894272 |
| 98 | Vitreoretinal degeneration (HP:0000655) | 1.86686000 |
| 99 | Alveolar cell carcinoma (HP:0006519) | 1.86483323 |
| 100 | Complement deficiency (HP:0004431) | 1.85751828 |
| 101 | Renal salt wasting (HP:0000127) | 1.85672632 |
| 102 | Thyroid carcinoma (HP:0002890) | 1.85663607 |
| 103 | Cardiovascular calcification (HP:0011915) | 1.84737339 |
| 104 | Ventricular tachycardia (HP:0004756) | 1.84468114 |
| 105 | Neoplasm of the liver (HP:0002896) | 1.82379157 |
| 106 | Abnormality of the lacrimal duct (HP:0011481) | 1.81414313 |
| 107 | Arnold-Chiari malformation (HP:0002308) | 1.81380782 |
| 108 | Bifid scrotum (HP:0000048) | 1.80012709 |
| 109 | Limited hip movement (HP:0008800) | 1.79509387 |
| 110 | Onycholysis (HP:0001806) | 1.78714412 |
| 111 | Abnormal foot bone ossification (HP:0010675) | 1.78708762 |
| 112 | Anophthalmia (HP:0000528) | 1.78281847 |
| 113 | Vascular calcification (HP:0004934) | 1.77707647 |
| 114 | Shallow orbits (HP:0000586) | 1.76951684 |
| 115 | Cutaneous syndactyly (HP:0012725) | 1.76788247 |
| 116 | Pterygium (HP:0001059) | 1.76783294 |
| 117 | Asymmetry of the thorax (HP:0001555) | 1.76561482 |
| 118 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.76445780 |
| 119 | Decreased lacrimation (HP:0000633) | 1.76426770 |
| 120 | Carpal synostosis (HP:0009702) | 1.76406556 |
| 121 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.75323837 |
| 122 | Abnormal pancreas size (HP:0012094) | 1.73903374 |
| 123 | Absent eyelashes (HP:0000561) | 1.72618613 |
| 124 | Hypokalemic alkalosis (HP:0001949) | 1.72254843 |
| 125 | Wide nose (HP:0000445) | 1.72017026 |
| 126 | Abnormality of purine metabolism (HP:0004352) | 1.72015845 |
| 127 | Morphological abnormality of the inner ear (HP:0011390) | 1.71494617 |
| 128 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.71140042 |
| 129 | Hyperuricemia (HP:0002149) | 1.71044581 |
| 130 | Increased purine levels (HP:0004368) | 1.71044581 |
| 131 | High anterior hairline (HP:0009890) | 1.70730756 |
| 132 | Mixed hearing impairment (HP:0000410) | 1.69848475 |
| 133 | Hyperaldosteronism (HP:0000859) | 1.69284172 |
| 134 | Broad palm (HP:0001169) | 1.69246219 |
| 135 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.68565847 |
| 136 | Synostosis involving bones of the feet (HP:0009140) | 1.68565847 |
| 137 | Abnormality of the common coagulation pathway (HP:0010990) | 1.68418894 |
| 138 | Synostosis of carpal bones (HP:0005048) | 1.67880044 |
| 139 | Pseudobulbar signs (HP:0002200) | 1.67282675 |
| 140 | Hypoplastic labia majora (HP:0000059) | 1.67087622 |
| 141 | Midline defect of the nose (HP:0004122) | 1.66811003 |
| 142 | Steatorrhea (HP:0002570) | 1.66534169 |
| 143 | Short middle phalanx of the 5th finger (HP:0004220) | 1.65949612 |
| 144 | Embryonal renal neoplasm (HP:0011794) | 1.65748095 |
| 145 | Tarsal synostosis (HP:0008368) | 1.65328725 |
| 146 | Short humerus (HP:0005792) | 1.65030104 |
| 147 | Rickets (HP:0002748) | 1.64479074 |
| 148 | Transposition of the great arteries (HP:0001669) | 1.64460278 |
| 149 | Abnormal connection of the cardiac segments (HP:0011545) | 1.64460278 |
| 150 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.64460278 |
| 151 | Pigmentary retinal degeneration (HP:0001146) | 1.63611853 |
| 152 | Ketoacidosis (HP:0001993) | 1.63460483 |
| 153 | Atrophic scars (HP:0001075) | 1.63200000 |
| 154 | Abnormal vertebral ossification (HP:0100569) | 1.63115691 |
| 155 | Omphalocele (HP:0001539) | 1.62746615 |
| 156 | Vascular tortuosity (HP:0004948) | 1.62621732 |
| 157 | Hypercholesterolemia (HP:0003124) | 1.62383622 |
| 158 | Malnutrition (HP:0004395) | 1.62331280 |
| 159 | Maternal diabetes (HP:0009800) | 1.61940551 |
| 160 | Hemorrhage of the eye (HP:0011885) | 1.61849865 |
| 161 | Advanced eruption of teeth (HP:0006288) | 1.61071055 |
| 162 | Abnormality of the nasolacrimal system (HP:0000614) | 1.60743466 |
| 163 | Hypoglycemic seizures (HP:0002173) | 1.58184467 |
| 164 | Abnormality of the lumbar spine (HP:0100712) | 1.56681704 |
| 165 | Tracheal stenosis (HP:0002777) | 1.56523883 |
| 166 | Abnormality of the ischium (HP:0003174) | 1.54650129 |
| 167 | Short middle phalanx of finger (HP:0005819) | 1.53982482 |
| 168 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.53928224 |
| 169 | Vertebral arch anomaly (HP:0008438) | 1.51647448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.85936733 |
| 2 | LMTK2 | 4.50890497 |
| 3 | STK38L | 3.39596282 |
| 4 | ZAK | 3.09034742 |
| 5 | LATS1 | 2.94287527 |
| 6 | ERBB3 | 2.89699244 |
| 7 | AKT3 | 2.73602479 |
| 8 | MAP3K10 | 2.28876615 |
| 9 | MKNK2 | 2.25294154 |
| 10 | BCKDK | 2.21699318 |
| 11 | SGK2 | 2.08987628 |
| 12 | EPHA2 | 1.98682001 |
| 13 | MKNK1 | 1.92788054 |
| 14 | FGFR4 | 1.88959642 |
| 15 | MAP3K3 | 1.81953722 |
| 16 | WNK3 | 1.68813018 |
| 17 | NEK1 | 1.67554216 |
| 18 | DDR2 | 1.61867577 |
| 19 | FER | 1.60533092 |
| 20 | SGK3 | 1.57411781 |
| 21 | NUAK1 | 1.56746286 |
| 22 | SGK223 | 1.54710989 |
| 23 | SGK494 | 1.54710989 |
| 24 | BRSK2 | 1.50241787 |
| 25 | FLT3 | 1.47644958 |
| 26 | ICK | 1.45472193 |
| 27 | MST4 | 1.44929326 |
| 28 | ERBB4 | 1.42478846 |
| 29 | PBK | 1.39489473 |
| 30 | SIK1 | 1.39311781 |
| 31 | MAP3K2 | 1.37629352 |
| 32 | PIK3CA | 1.36203415 |
| 33 | TRPM7 | 1.33177200 |
| 34 | EEF2K | 1.30321886 |
| 35 | WNK4 | 1.27748091 |
| 36 | EPHA4 | 1.26422189 |
| 37 | EPHB2 | 1.20445718 |
| 38 | BRD4 | 1.20197602 |
| 39 | OXSR1 | 1.19638112 |
| 40 | BMPR2 | 1.18604338 |
| 41 | DMPK | 1.18414525 |
| 42 | PRPF4B | 1.17759316 |
| 43 | PLK4 | 1.17137519 |
| 44 | TYRO3 | 1.16574819 |
| 45 | PRKG2 | 1.13794379 |
| 46 | STK3 | 1.10743140 |
| 47 | PLK3 | 1.08542610 |
| 48 | PAK4 | 1.04925603 |
| 49 | STK39 | 1.04585154 |
| 50 | ACVR1B | 1.02780236 |
| 51 | MST1R | 1.02304580 |
| 52 | NEK6 | 1.02135966 |
| 53 | CDC7 | 1.01647423 |
| 54 | PTK2 | 1.00747445 |
| 55 | WEE1 | 0.99779497 |
| 56 | RPS6KB2 | 0.99583819 |
| 57 | LATS2 | 0.97398418 |
| 58 | STK24 | 0.96660574 |
| 59 | SRPK1 | 0.96340258 |
| 60 | FGFR3 | 0.96109611 |
| 61 | PINK1 | 0.94344563 |
| 62 | NTRK1 | 0.93847590 |
| 63 | CAMK1G | 0.93828869 |
| 64 | PDK2 | 0.92026749 |
| 65 | TSSK6 | 0.91749108 |
| 66 | OBSCN | 0.91438794 |
| 67 | PDGFRB | 0.88742047 |
| 68 | RIPK1 | 0.88689501 |
| 69 | BCR | 0.88141437 |
| 70 | TNIK | 0.86169782 |
| 71 | CDK6 | 0.84368409 |
| 72 | PKN2 | 0.82942974 |
| 73 | NEK2 | 0.81402467 |
| 74 | MTOR | 0.80916910 |
| 75 | CAMK1D | 0.80631904 |
| 76 | BMX | 0.74616683 |
| 77 | STK4 | 0.74125492 |
| 78 | ROCK1 | 0.73418557 |
| 79 | YES1 | 0.73086530 |
| 80 | PTK6 | 0.70093823 |
| 81 | PLK2 | 0.68095272 |
| 82 | FGFR1 | 0.67757058 |
| 83 | PRKCI | 0.67736126 |
| 84 | TTN | 0.67397171 |
| 85 | TTK | 0.67337501 |
| 86 | CASK | 0.65874728 |
| 87 | PDGFRA | 0.65770662 |
| 88 | MET | 0.65564284 |
| 89 | ERBB2 | 0.65196453 |
| 90 | FGFR2 | 0.64304768 |
| 91 | PNCK | 0.63821822 |
| 92 | PDK3 | 0.63616838 |
| 93 | PDK4 | 0.63616838 |
| 94 | MAP2K1 | 0.63323724 |
| 95 | RET | 0.63308216 |
| 96 | PAK3 | 0.62789186 |
| 97 | CDK7 | 0.60164721 |
| 98 | NLK | 0.59725505 |
| 99 | CDK12 | 0.58629275 |
| 100 | KSR1 | 0.58173944 |
| 101 | PRKAA1 | 0.56673794 |
| 102 | MAP3K4 | 0.56346458 |
| 103 | CSNK1E | 0.54764317 |
| 104 | DYRK3 | 0.54597972 |
| 105 | RPS6KB1 | 0.53813358 |
| 106 | TESK1 | 0.53596963 |
| 107 | NEK9 | 0.51342392 |
| 108 | MAP3K6 | 0.51148714 |
| 109 | NME1 | 0.50447797 |
| 110 | PAK2 | 0.49321062 |
| 111 | GSK3A | 0.49216186 |
| 112 | PRKCE | 0.48508494 |
| 113 | SCYL2 | 0.47912620 |
| 114 | CHUK | 0.47056874 |
| 115 | MYLK | 0.45634986 |
| 116 | BRSK1 | 0.45589741 |
| 117 | TAF1 | 0.44809798 |
| 118 | PLK1 | 0.44314973 |
| 119 | MELK | 0.44099101 |
| 120 | CHEK2 | 0.40739165 |
| 121 | MAPK7 | 0.39364759 |
| 122 | CSNK1G1 | 0.38667076 |
| 123 | BUB1 | 0.38503844 |
| 124 | AURKA | 0.38355897 |
| 125 | TRIB3 | 0.37442192 |
| 126 | SGK1 | 0.37329058 |
| 127 | PRKAA2 | 0.35005006 |
| 128 | LIMK1 | 0.34805352 |
| 129 | AURKB | 0.33715186 |
| 130 | DYRK1B | 0.31363536 |
| 131 | TAOK2 | 0.31304255 |
| 132 | AKT2 | 0.30922530 |
| 133 | MAPK15 | 0.30797266 |
| 134 | WNK1 | 0.30509263 |
| 135 | ATM | 0.30177031 |
| 136 | DYRK1A | 0.30067348 |
| 137 | SIK3 | 0.27762354 |
| 138 | CSNK1A1 | 0.26366879 |
| 139 | RPS6KL1 | 0.25684002 |
| 140 | RPS6KC1 | 0.25684002 |
| 141 | CDC42BPA | 0.25310432 |
| 142 | EIF2AK2 | 0.24555869 |
| 143 | PRKD3 | 0.24061346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.06713561 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.79967680 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.53630271 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.75800692 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.72290097 |
| 6 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.69599251 |
| 7 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.50070011 |
| 8 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.40206833 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10662366 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06549393 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.03867505 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.00475161 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.99248808 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98147020 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92550987 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.86640921 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.79211767 |
| 18 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.77471953 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.76206645 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75872085 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.74839531 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65343830 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64365187 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.62356628 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60056110 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58991123 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.48778824 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43810488 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.41061383 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.36206045 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.35738025 |
| 32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.35016603 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.34515690 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33604042 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.30113151 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27268813 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24384742 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23517819 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.22660342 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21961526 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19459849 |
| 42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.18523894 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.15835034 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14815704 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13717481 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12819107 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10912369 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 1.09345448 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09136942 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03500641 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02119761 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.01125819 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 1.00843951 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99825729 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94407980 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93479110 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93430271 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86471399 |
| 59 | Adherens junction_Homo sapiens_hsa04520 | 0.84659275 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83691121 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82967259 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82534463 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.82295945 |
| 64 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78688395 |
| 65 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.77527111 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77493543 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77204049 |
| 68 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73356007 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72841576 |
| 70 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72840408 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72647369 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70910777 |
| 73 | Tight junction_Homo sapiens_hsa04530 | 0.70631388 |
| 74 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.68617571 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68224140 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67916946 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.67688667 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66418630 |
| 79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66337527 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65406162 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64916699 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62893148 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62716332 |
| 84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60673651 |
| 85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58394973 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58376804 |
| 87 | Axon guidance_Homo sapiens_hsa04360 | 0.56720395 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55122531 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52838250 |
| 90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52025911 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48896987 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46836432 |
| 93 | Cell cycle_Homo sapiens_hsa04110 | 0.46475364 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45990385 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44659342 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42437510 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.42388009 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40634441 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38179959 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34650181 |
| 101 | Melanoma_Homo sapiens_hsa05218 | 0.34258651 |
| 102 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33337530 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30599537 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29009970 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27939667 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25951832 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25476420 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22623791 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20715612 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.20010276 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19754986 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18815716 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18183562 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.17380526 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16915356 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.15856406 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.15190519 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.14470185 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.14399773 |

